Understanding Equine Monocytic Ehrlichiosis
Equine Disease Quarterly
October 4, 2013
Equine monocytic ehrlichiosi (EME) has case fatality rates ranging from 5 to 30%.
Horse-health-problem risk factors, prevention, diagnosis, and treatment
Equine monocytic ehrlichiosi (EME) has case fatality rates ranging from 5 to 30%.
Officials confirmed Oregon’s third case, while a fifth Kentucky horse tested positive for WNV.
Of 400 participants, 79% said they’d never heard of the bacterium and only 5% had known a horse with it.
As of Sept. 25, 139 cases of EEE and 157 cases of WNV have been reported in horses nationwide.
Dr. Gary Priest of Versailles, Ky., presents equine respiratory disease case studies identified via dynamic endoscopy.
Anesthesiologists have developed a simple and inexpensive device for equine ventilation in a field emergency.
Harlow’s research has focused on exploring options for reducing gastrointestinal conditions in the horse.
This plant contains toxins that can cause digestive issues, appetite loss, and neurologic problems in horses.
A horse in Chatham County has tested positive for EEE, environmental health officials announced Sept. 26.
The 7-year-old Quarter Horse gelding was recently pastured in Outlook, Wash., and has no vaccination history.
Wyoming animal health officials encourage owners to vaccinate horses against the potentially deadly virus.
Researchers are exploring the use of renal replacement therapy to help horses with acute renal failure.
This is the first equine WNV case and the fourth equine EEE case confirmed in Massachusetts this year.
The unvaccinated 8-year-old Percheron/Standardbred cross mare is reportedly recovering.
Despite receiving supportive care, the yearling filly showed no improvement and was euthanized.
Gray Quarter Horses could be less susceptible to melanomas compared to grays of other breeds.
Stay on top of the most recent Horse Health news with
